Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07075731 · ClinicalTrials.gov registry record

Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy

A clinical trial of Cancer Screening and Transgender, sponsored by University of Minnesota.

Recruiting
Registry status
40
Enrollment target
1
Study location

NCT07075731 is a study of Cancer Screening and Transgender that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 40 participants, below the 677-participant average among 4 other Cancer Screening trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07075731, a study of Cancer Screening and Transgender, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
40 participants
Enrollment target
1
Study location

Study Summary

This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hysterectomy pathology, this study will provide preliminary data on the current state of guideline-concordant care and provide initial evidence for the development of evidence-based guidelines in the future

Interventions

  • OTHER No intervention

Study Locations (1)

Minnesota

  • University of Minnesota - Minneota

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-06-30
Est. Completion 2027-06-30

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT07075731

The ClinicalTrials.gov registry entry for NCT07075731 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 677-participant average among 4 other Cancer Screening trials with a reported enrollment target (94% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.

NCT07075731 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT07075731 about?

NCT07075731 is a clinical study titled "Cervical and Endometrial Cancer Screening in Patients Seeking Gender-Affirming Hysterectomy". This study aims to quantify the rates of cervical cancer screening and endometrial sampling prior to gender-affirming hysterectomy, assess the need for these tests in TGD individuals, and explore patient-centered options for these tests. By assessing the status of testing and correlation with hyster...

What is the current status of trial NCT07075731?

This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-06-30. Estimated completion is 2027-06-30.

What conditions does trial NCT07075731 study?

This clinical trial studies the following conditions: Cancer Screening, Transgender, Gender Diverse Populations.

What interventions are being tested in trial NCT07075731?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT07075731?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07075731 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.